A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm

Leukemia

Volumn 27, Issue 5, 2013, Pages 1186-1188

  Gervais, C ^a,b,c   Dano, L ^a,b,c   Perrusson, N ^d   Helias C ^a,b,c   Jeandidier, E ^b,c   Galoisy, A C ^a,c   Ittel, A ^a,b,c   Herbrecht, R ^a   Bilger, K ^a   Mauvieux, L ^a,b,c,d  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Laboratoire Regional de Cytogenetique Hematologique D'Alsace Mulhouse Strasbourg   (France)

^c Plate forme Régionale INCa de Génétique Moléculaire des Cancers d'Alsace   (France)

^d service d'hématologie biologique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EXPORTIN 5; FIBROBLAST GROWTH FACTOR RECEPTOR 1;

ADULT; CASE REPORT; CHROMOSOME 2; CHROMOSOME TRANSLOCATION 8; CLINICAL FEATURE; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; LETTER; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE NEOPLASM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR CHAPERONES; MYELODYSPLASTIC-MYELOPROLIFERATIVE DISEASES; NUCLEAR PORE COMPLEX PROTEINS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; TRANSLOCATION, GENETIC;

EID: 84877622702     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.286     Document Type: Letter

References (15)

1. Swerdlow SH, Campo E, Harris NL, JafféES, Pileri SA, Stein H et al. WHO Classification of Tumours of Haematopoietic and lymphoid tissues. IARC: Lyon, 2008.
2. Li F, Zhai YP, Tang YM, Wang LP, Wan PJ. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer 2012; 51: 890-897.
3. Wasag B, Lierman E, Meeus P, Cools J, Vandenberghe P. The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11). Haematologica 2011; 96: 922-926.
4. Jackson CC, Medeiros LJ, Miranda RN. 8p11 myeloproliferative syndrome: a review. Hum Pathol 2010; 41: 461-476.
5. Shaffer LG, Slovak ML, Campbell LJ. An International System for Human Cytogenetic Nomenclature. Karger: Basel, 2009.
6. Ma Z, Hill DA, Collins MH, Morris SW, Sumegi J, Zhou M et al. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2003; 37: 98-105.
7. Hidalgo-Curtis C, Chase A, Drachenberg M, Roberts MW, Finkelstein JZ, Mould S et al. The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1. Genes Chromosomes Cancer 2008; 47: 379-385.
8. Soler G, Nusbaum S, Varet B, Macintyre EA, Vekemans M, Romana SP et al. LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndrome. Leukemia 2009; 23: 1359-1361.
9. Wu J, Matunis MJ, Kraemer D, Blobel G, Coutavas E. Nup358, a cytoplasmically exposed nucleoporin with peptide repeats, Ran-GTP binding sites, zinc fingers, a cyclophilin A homologous domain, and a leucine-rich region. J Biol Chem 1995; 270: 14209-14213.
10. Bernad R, van der Velde H, Fornerod M, Pickersgill H. Nup358/RanBP2 attaches to the nuclear pore complex via association with Nup88 and Nup214/CAN and plays a supporting role in CRM1-mediated nuclear protein export. Mol Cell Biol 2004; 24: 2373-2384.
11. Patel AS, Murphy KM, Hawkins AL, Cohen JS, Long PP, Perlman EJ et al. RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors. Cancer Genet Cytogenet 2007; 176: 107-114.
12. Chen ST, Lee JC. An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features. Hum Pathol 2008; 39: 1854-1858.
13. Rottgers S, Gombert M, Teigler-Schlegel A, Busch K, Gamerdinger U, Slany R et al. ALK fusion genes in children with atypical myeloproliferative leukemia. Leukemia 2010; 24: 1197-1200.
14. Aslanukov A, Bhowmick R, Guruju M, Oswald J, Raz D, Bush RA et al. RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism. PLoS Genet 2006; 2: e177.
15. Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 2004; 36: 1084-1089.